Transdifferentiation is the name used to describe the conversion of one differentiated cell type to another. During development, the liver and pancreas arise from the same region of the endoderm and cells from the two organs can transdifferentiate in the adult under different experimental procedures. We have produced two in vitro models for the transdifferentiation of pancreatic cells to hepatocytes. T h e first utilizes a pancreatic exocrine cell line AR42J-B13 and the second comprises cultures of mouse embryonic pancreas. We have analysed the pancreatic hepatocytes and they express a range of liver markers including albumin, transferrin and transthyretin. We also present evidence for (i) the molecular mechanism which regulates the conversion between pancreas and liver and (ii) the cellular basis of the switch in phenotype.
Introduction
T h e ability of one differentiated cell type to convert to another is termed transdifferentiation or metaplasia [l-31. The process of transdifferentiation is important for two reasons. Firstly, for understanding the molecular and cellular basis of embryonic development, as the conversion of one cell type to another generally occurs between cells which arise from neighbouring regions of the same K e y words: C/ESPB, exocrine, glucocorticoid. liver, transdifferentiation. Abbreviations used: HGF, hepatocyte growth factor: Dex, dexamethasone: LETF, liver-enriched transcription factor: GFP, green fluorescent protein: C/EBP, CCAAT/enhancer-binding protein. ' To whom correspondence should be addressed (e-mail d.tosh@bath.ac.uk).
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germ layer (mesoderm, endoderm or ectoderm) [l-31. Secondly, transdifferentiation leads to a predisposition towards certain neoplastic transformations and therefore elucidating the molecular basis of the conversion will also provide information on the processes underlying the development of cancer [2] .
In order to demonstrate that transdifferentiation has occurred in a system, Eguchi and Kodama [4] suggested that two prerequisites be fulfilled. The first involves demonstrating (preferably with molecular evidence) the differentiation state of the two cells types before and after the transdifferentiation event. The second prerequisite involves showing a direct ancestor-descendent relationship between the cells prior to and following transdifferentiation. It is difficult to fulfil these prerequisites under in vivo conditions. However, in vitro culture systems are more amenable to testing these prerequisites. One of the beststudied in vitro models for transdifferentiation is the conversion of pigmented epithelial cells of the retina to lens cells, so-called Wolffian lens regeneration [4] . Developing in vitro models for the transdifferentiation of one cell type to another is crucial as it will allow us to define the molecular and cellular mechanisms which distinguish the two cell types involved in the switch. . The exocrine-specific elastase promoter was used to drive G F P and transfected into B13 cells. After the cells were induced to undergo transdifferentiation by culture with Dex it was possible to detect G F P and liver markers in the same cell. This experiment clearly shows that the hepatocytes must have arisen from cells which had an active elastase promoter at one time, i.e. were differentiated exocrine cells. Such a direct conversion between one differentiated cell type (exocrine cell) and another (hepatocyte) is a true transdifferentiation event.
Models for the transdifferentiation of pancreas to liver
Within the pancreas a variety of cell types have been proposed to give rise to hepatocytes, including exocrine and endocrine cells (glucagon-, insulin-and somatostatin-secreting cells) as well as the ductular system which carries the digestive enzymes to the small intestine. Although several experimental models support the concept that cells capable of transdifferentiating to hepatocytes exist in the pancreas, there is no consensus as to which are the progenitor cells. In contrast to the in vitro experiments on B13 cells and embryonic pancreatic buds, which suggest that cells with an exocrine phenotype are the hepatocyte precursors, overexpression of keratinocyte growth factor in the pancreatic islets of transgenic mice results in development of hepatocytes within the islets. This result suggests that at least one type of endocrine cell may have the potential to undergo transdifferentiation to hepatocytes [ l l ] . Induction of hepatocytes by treating rats with the peroxisomal proliferator ciprofibrate results in an intermediate phenotype with characteristics of either exocrine or endocrine cells [lo] . Isolation of pancreatic epithelial cells followed by transplantation into the liver also acts as a source of hepatocytes [7] . In the copper-deficiency model of transdifferentiation of pancreas to liver, oval cells residing in the ducts are thought to be the source of hepatocytes [22] , but more recent transplantation suggests that cells other than those of ductal origin may be the source of hepatocytes [8] .
Molecular basis of transdifferentiation of pancreas to liver
T h e conversion of pancreatic cells to hepatocytes provides the novel opportunity to study the molecular basis of transdifferentiation and perhaps identify the master-switch gene for pancreas to liver in the process. T o understand the molecular basis of the switch a number of approaches have been taken. Using different experimental model systems the expression of known liver-enriched transcription factors (LETFs) has been examined following the conversion of pancreatic cells to hepatocytes [23, 24] . The first to appear during the copper-deprivation phase are members of the CCAAT/enhancer-binding protein ( C / E B P ) family, C/EBPa, p and 6 [23, 24] . In addition, 
Future directions
Although many of the details of the transdifferentiation of pancreas to liver are now established, some questions still remain to be answered. In particular, the role of C/EBPj? (and other members of the C/EBP family) in normal liver development is poorly understood. Since there is an element of redundancy within the C/EBP family it is apparent that the answer will not come from simple single-gene-knockout studies but rather simultaneous knockouts of all the members. It is also necessary to determine whether hepatocytes can arise from pancreatic cell types apart from exocrine cells and whether the transdifferentiation of exocrine cells to hepatocytes has any real significance with respect to the situation in humans. Finally, while it is possible to convert pancreatic B13 cells and embryonic pancreatic cells to hepatocytes by addition of Dex, it is still unclear whether the hepatocytes formed express the full complement of liver markers. Should it turn out that these cells express many liver markers then there is enormous potential in these hepatocytes to study the factors which regulate hepatic gene expression and functions (e.g. Phase I and I1 pathways of detoxification).
